Other
Qidong Liver Cancer Institute
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
40%
2 of 5 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
Phase 1
2(40.0%)
Phase 2
1(20.0%)
N/A
1(20.0%)
Phase 4
1(20.0%)
5Total
Phase 1(2)
Phase 2(1)
N/A(1)
Phase 4(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT03399656Not ApplicableCompleted
Broccoli Supplement Dose Response
Role: collaborator
NCT02656420Phase 1Completed
Broccoli Sprout Dose Response: Bioavailability and Effects of Air Pollutants
Role: collaborator
NCT01437501Phase 2Completed
Broccoli Sprout Intervention in Qidong, P.R. China
Role: collaborator
NCT01008826Phase 1Completed
Cross-Over Broccoli Sprouts Trial
Role: collaborator
NCT00222664Phase 4Completed
Qidong Hepatitis B Intervention Study
Role: collaborator
All 5 trials loaded